UBS AM’s THERATECHNOLOGIES INC COM THER Stock Holding History

UBS AM’s Portfolio THER Stock Details THER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-35,551	Closed	-$57.2K	–	2605
2020 Q1	$57.2K	Buy	+35,551	New	+$57.2K	﹤0.01%	2427

Other funds holding THER

Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hamilton Capital Columbus, Ohio $1.93B AUM

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS AM's THER Position: Q2 2020 in Review

UBS AM sold out of THERATECHNOLOGIES INC COM (THER) in Q2 2020, closing a stake of 35,551 shares — an estimated $57.2K sold.

UBS AM first reported a position in THER in Q1 2020 and held it in 1 quarter. The position peaked at $57.2K in Q1 2020. 36 funds tracked by Wall St. Rank hold THER as of Q2 2020.

UBS AM reported no remaining THERATECHNOLOGIES INC COM position as of Q2 2020 after selling out during the quarter.
UBS AM sold 35,551 THERATECHNOLOGIES INC COM shares in Q2 2020, an estimated $57.2K.
UBS AM first reported a position in THERATECHNOLOGIES INC COM in Q1 2020 and held it in 1 quarter.
UBS AM's THERATECHNOLOGIES INC COM position peaked at $57.2K in Q1 2020.
36 funds tracked by Wall St. Rank held THERATECHNOLOGIES INC COM as of Q2 2020.

Based on UBS AM's 13F filing for Q2 2020, filed 14 Aug 2020.